Droplet precautions
If the patient is in an area in which they are in contact with other patients or need to be transported and thus may come in close contact (<3 feet) with staff, visitors, or other patients, the patient needs to wear a surgical mask (or N-95 respirator, if not available).
If the patient is in an area in which they are in contact with other patients or need to be transported and thus may come in close contact (<3 feet) with staff, visitors, or other patients, the patient needs to wear a surgical mask (or N-95 respirator, if not available).
Despite questions on efficacy and safety, CDC still recommends treatment for all hospitalized patients and outpatients at risk for complications
Treatment: any age
Prophylaxis: >3 months
Adverse events: nausea, vomiting. Sporadic, transient neuropsychiatric events (self-injury or delirium) mainly reported among Japanese adolescents and adults.
Treatment: >7 yrs
Prophylaxis >5 years
Allergic reactions: oropharyngeal or facial edema.
Adverse events: diarrhea, nausea, sinusitis, nasal signs and symptoms, bronchitis, cough, headache, dizziness, and ear, nose and throat infections.
Treatment: >12 years
Prophylaxis: not yet approved for this indication
Adverse Events: diarrhea, bronchitis, nausea, common cold symptoms (nasopharyngitis) and headache
Allergic reactions: oropharyngeal or facial edema
Shorten duration of illness by 16.8 hrs while NNTH (number needed to harm) was 28 in regards to causing nausea/vomiting, headache and renal and psych syndromes
Greatest benefit if within 48hrs of symptom onset
However, may be beneficial up to 4-5 days, including in pregnant patients
Early treatment of hospitalized patients can reduce death
However, may be beneficial up to 4-5 days, including in pregnant patients
Early treatment of hospitalized patients can reduce death
Age <1 year: 3mg/kg PO BID x 5 days
<15kg: 30mg PO BID x 5 days
15-23kg: 45mg PO BID x 5 days
24-40kg: 60mg PO BID x5d
Adult: 75mg PO BID x 5 days
Relatively contraindicated in patients with asthma, COPD, or pregnancy. Shorten duration of illness by 14.4 hrs with no reduction in<unk> -related complications
Age >7yo: 10mg (2 inhalations) BID x 5d
Prophylaxis: 10mg (2 inhalations) once daily x 7 days
Not for age < 5yo
Not for age < 5yo
Only approved for patients >12 years old and >40kg in weight, no current safety data exists for pregnancy and breastfeeding. More expensive but one time dosing. Genentech, its creator, states a recent phase III trial has shown it to be effective for prophylaxis but not currently FDA indicated for this.
Weight between 40-80kg: 40mg PO once (20 mg tab x2)
Weight >80kg: 80mg PO once (40mg tab x2)
Prophlyaxis: not yet approved for this indication by CDC or FDA
Amantadine and other M2 viral proton channel blockers are no longer indicated for<unk>  treatment due to nearly 100% resistance
Influenza
Pertussis
URI
Rubella
Pneumonia
Anthrax
Sinusitis
Diphtheria